There is a news from Jabalpur, Madhya Pradesh… that there was a baby born with 5.2 kilo weight. Well, this huge weight is very uncommon.
Such babies are called LGA, large for gestational age, or LFD, large for date.
I remember… personally taking care of a baby born with a similar weight, 5.2 kilo, in Chicago, to a Mexican mother. It was a male baby, and I remember, around day four or five, he developed fever. Pyrexia in newborn babies is a serious matter, and this baby ended up getting treated for Candida septicemia.
Not to forget, large-for-gestational age can be due to many factors, but clinically, the first thing which comes to our mind is diabetic mom. But sometime, such babies are just constitutionally large. And there’s another thing, Sotos syndrome.
Well, Post term pregnancy will lead to growth restriction ( IUGR) and not large babies. Because in post dated pregnancy ( beyond 42 weeks of gestation ), amniotic fluid starts decreasing, leading to fetal growth restriction.
We love when the babies are born around 40 weeks. Post dated pregnancy also leads to increased risk of meconium aspiration.
Fetal macrosomia means your newborn is larger than average. It’s also called “large for gestational age.” Certain factors can increase the risk of having a big baby, like diabetes and obesity. Delivering a baby with fetal macrosomia can cause complications. But most births are uncomplicated.
LGA babies emerge from more than just maternal diabetes. Look at maternal obesity as a cause of extra calories, or extended gestation giving the fetus excess growth time. Heredity, multiparity, and large parent bodies are in the picture. High maternal glucose causes fetal insulin spikes that result in these babies being larger, but delivery more perilous.
This extraordinary case of a 5.2 kg newborn in Jabalpur underscores both the progress in maternal health and the complexities that accompany macrosomic births. While enhanced prenatal care and nutrition play key roles in supporting fetal growth, this birth also highlights the importance of rigorous neonatal monitoring—particularly for hypoglycemia and congenital risks. It serves as a valuable reminder for clinicians to balance optimal maternal health strategies with preparedness for managing atypical outcomes—ensuring both mother and child remain in stable condition.
